VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
about
Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor.Extracellular matrix and growth factor engineering for controlled angiogenesis in regenerative medicineImproved Angiogenesis in Response to Localized Delivery of Macrophage-Recruiting MoleculesComparative molecular developmental aspects of the mammalian- and the avian lungs, and the insectan tracheal system by branching morphogenesis: recent advances and future directionsAngiopoietin 2 alters pancreatic vascularization in diabetic conditionsVEGF guides angiogenic sprouting utilizing endothelial tip cell filopodiaThe WNT antagonist Dickkopf2 promotes angiogenesis in rodent and human endothelial cells.Coadministration of adenoviral vascular endothelial growth factor and angiopoietin-1 enhances vascularization and reduces ventricular remodeling in the infarcted myocardium of type 1 diabetic rats.Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent.Polymer transfected primary myoblasts mediated efficient gene expression and angiogenic proliferation.Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.Neurorestorative therapy for strokeRandomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904.Cardiac-specific overexpression of HIF-1{alpha} prevents deterioration of glycolytic pathway and cardiac remodeling in streptozotocin-induced diabetic mice.Low energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylation.Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart modelConditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy.Biologically active fragment of a human tRNA synthetase inhibits fluid shear stress-activated responses of endothelial cells.Endothelial differentiation of mesenchymal stromal cellsPeptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis.Molecular control of capillary growth in skeletal muscle.Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis.Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesisVascular endothelial growth factor (VEGF) in seizures: a double-edged sword.Cardiovascular gene delivery: The good road is awaitingMnTBAP stimulates angiogenic functions in endothelial cells through mitofusin-1.Lymphangiogenic gene therapy with minimal blood vascular side effectsThe effect of controlled expression of VEGF by transduced myoblasts in a cardiac patch on vascularization in a mouse model of myocardial infarctionNew strategies for cardiovascular gene therapy: regulatable pre-emptive expression of pro-angiogenic and antioxidant genesVascular endothelial growth factor is up-regulated after status epilepticus and protects against seizure-induced neuronal loss in hippocampusPeptide-based molecules in angiogenesis.Long-term safety and stability of angiogenesis induced by balanced single-vector co-expression of PDGF-BB and VEGF164 in skeletal muscle.Controlled Angiogenesis in Peptide Nanofiber Composite HydrogelsCXCR4-gp120-IIIB interactions induce caspase-mediated apoptosis of prostate cancer cells and inhibit tumor growthClinical application of growth factors and cytokines in wound healingRevascularization of trachea in lung and tracheal transplantation.Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy.In vivo properties of the proangiogenic peptide QKPGC-1 coactivators and skeletal muscle adaptations in health and disease.FACS-purified myoblasts producing controlled VEGF levels induce safe and stable angiogenesis in chronic hind limb ischemia.
P2860
Q24536055-A26B20DF-3436-47E8-AEFD-2344FAE77182Q26829783-4AD34F4F-6142-4BCB-8CDF-ACB44C7CD301Q27303518-56A5DC4A-E8E7-4B4D-8E2B-33F70E2C1738Q28710584-2D4E084B-D7BA-4A9C-832D-9841E5F1FFA1Q28732767-7F2F6073-1229-41C4-8FF4-7DB087D0EF55Q29617501-3C48C79C-F200-4DFF-9855-E5BF9EBE0B1CQ30499919-811AB71E-5155-4B36-8405-C9D0470F4555Q33556657-1C7D62E5-1FA9-4CFD-A5F6-890EE08E497FQ33586324-27D39EF1-A583-43FF-8053-68EB991466DEQ33653191-B4AA4E4B-D27A-4A43-ADC7-5C796AD4AA84Q33746524-7D946F38-82BD-4838-B7E1-F46A6FD42004Q33813333-64AE78AB-FB1C-4CC4-A97C-945BDFE2FB70Q33903078-40F1DB20-1719-409E-8AA5-27501A26AEAEQ33947175-7806A17F-C0E8-4016-9038-E57E48106F25Q34004811-EF9B8C23-8775-4E4C-9A20-A827C40E71CDQ34035800-115DEE2F-058F-49A6-B768-5994465DD7DFQ34086442-041C8D1B-B952-4818-A684-097C110E5176Q34388011-515DCC3D-1E40-417D-BB89-2F1133FD9930Q34442276-CBD4ACC8-C250-4DB9-90DA-3B8533D3557AQ34479397-F50B85E6-1154-4CB2-954B-6F0B27030B96Q34995545-E862325F-6BC0-495F-A45D-3BEBBC46D614Q35554334-DC3836CD-A8E7-41B8-B1E7-7D230897F345Q35804497-CE938E76-3289-4E7F-B503-D9A2BF7D72A4Q35834542-AA1C6F7A-4ED8-42BF-8220-FB21C0103262Q35915765-624928B5-8920-4343-ADA6-149DCB9A0AD0Q35991538-591C9CBC-1773-4ADC-B561-2C136029B9BBQ36371262-3D5EBDA9-72B8-441D-AD0C-9EFB42A94052Q36374351-C926EA48-B2AF-4E76-AE2E-A8F9008D3232Q36385632-D7747F11-CA35-4EF3-B4D4-A435DAC257A4Q36402077-AAD1228E-D97B-499C-B026-0F3BD002A80EQ36402580-94E46BA6-07EE-47E5-A69E-D0E6D04E2895Q36587779-B871ADEF-A983-4DA8-B760-EC4DC4DAAD71Q36623213-68434F5C-C2BB-47BE-B41F-9F7078DE42CBQ36693212-5AB8EED3-951C-4E75-B4D2-FC50A24E6C39Q36742273-65121468-19F8-4ABE-A42A-0344CB04B0F3Q36936440-C1A5DA38-67CA-46CA-8B2C-79FFA7C89034Q36973811-C3E76C96-552A-4488-AF1F-3866587FB359Q37242381-353A5B44-7402-4CCA-9229-AF55BE156BCBQ37265277-9AEBF9C1-8A37-431F-AA95-6EAAB80BB34CQ37295222-3F2B9992-AD8D-4F51-B0D3-077F7937925F
P2860
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
@en
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
@nl
type
label
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
@en
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
@nl
prefLabel
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
@en
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
@nl
P356
P1433
P1476
VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
@en
P2093
Carmeliet P
P2888
P304
P356
10.1038/80430
P407
P577
2000-10-01T00:00:00Z
P6179
1002127399